[Fundamental technologies for COVID-19] Creation of fundamental technologies by interdisciplinary research to coexist with infectious diseases including COVID-19

Strategic Objective

Technology infrastructure for the post-COVID society built by “Convergence of Knowledge”

Research supervisor


Aikichi Iwamoto (Director, Office of Project Management, Japan Agency for Medical Research and Development)


 This research area aims to create new strategies against the spread of SARS-CoV-2 and innovative technologies which lead to the new strategies, by interdisciplinary collaborations of researchers from a wide variety of research fields.
 The outbreak of COVID-19 is thought to have occurred in the city of Wuhan, China in December 2019, and the World Health Organization declared it a pandemic on March 11, 2020. It has had a tremendous impact on our daily life and the economic and social activities. Because of our concern about the re-spread of COVID-19 infection, the economy and the society have been forced to be stagnant for long periods of time. In these circumstances, it is urgently required to make our society resilient against infectious diseases and to promote science, technology and innovation in order to underpin the efforts.
 Thus, this project aims to minimize the impact which is caused by SARS-CoV-2 on our society, and also to create fundamental technologies to coexist with emerging or re-emerging infectious diseases including COVID-19 by utilizing a wide variety of science and technology in order to build a resilient society for the new normal with COVID-19 and the post-coronavirus future.

Research Area Advisors

Kiyoshi Asai Professor, Graduate School of Frontier Sciences, The University of Tokyo
Shigeru Kohno President, Nagasaki University
Yoshio Koyanagi Vice Director & Program-Specific Professor, The Institute for Liberal Arts and Sciences, Kyoto University
Shiro Saito Executive Fellow, Toshiba Corporation
Masao Ikeda-Saito Professor Emiritus, Tohoku University
Ai Tachikawa Division leader, AIDS Research Center, National Institute of Infectious Diseases
Katsushi Tokunaga Director, Genome Medical Science Project (Toyama), National Center for Global Health and Medicine
Tohru Natsume Prime Senior Researcher, Cellular and Molecular Biotechnology Research Institute, The National Institute of Advanced Industrial Science and Technology
Toshihiko Nishimura Director, Stanford Lab for Drug, Device Development& Regulatory Science;SLDDDRS, Stanford University
Makoto Fujimaki Director, Department of Electronics and Manufacturing, Research Planning Office, National Institute of Advanced Industrial Science and Technology
Hideo Maeda Director, Kita City Public Health Center

Research Projects

  1. Year Started : 2020

Quick Access


  • ACT-I
  • ACT-X
  • ALCA
  • manual
  • AIP Network Lab
  • Global Activities
  • Diversity
  • SDGs
  • OSpolicy
  • Yuugu
  • Questions